Modern Pediatrics. Ukraine. (2022). 7(127): 29-37. doi 10.15574/SP.2022.127.29
Voloshin O. M.¹, Marushko Yu. V.^2
1Luhansk State Medical University, Rivne, Ukraine
²Bogomolets National Medical University, Kyiv, Ukraine

For citation: Voloshin OM, Marushko YuV. (2022). Comprehensive analysis of serum concentration of matrix metalloproteinase 1 and tissue inhibitor of metalloproteinase 1 in preschool children suffering from recurrent respiratory infections. Modern Pediatrics. Ukraine. 7(127): 29-37. doi 10.15574/SP.2022.127.29.
Article received: Sep 11, 2022. Accepted for publication: Nov 15, 2022.

Purpose – to systematically examine the state of interrelatedness between the serum concentration of matrix metalloproteinase 1 and the tissue inhibitor of metalloproteinase 1, the frequency of acute respiratory infections (ARIs), and a heterogeneous set of other clinical and laboratory parameters in preschool children.
Materials and methods. Forty children (21 boy and 33 girls) aged 1 to 6 years old, undergoing inpatient treatment on acute respiratory infection, were involved in the clinical study. They were studied serum concentrations of MMP-1 and TIMP-1, C-reactive protein, certain blood leukocyte fractions, erythrocyte sedimentation rate, the content of several macro- and microbiological elements in their hair as well as a number of clinical signs. Also, two integral indicators of ARIs recurrence were calculated, namely, the infectious index (InI) and resistance index, as well as integral indices of inflammation and dolichostenomelia. The statistical processing of the primary digital material obtained was performed by IBM SPSS Statistics 27 licensed program.
Results. The younger children had higher serum MMP-1 concentrations (p=0.007) and MMP-1/TIMP-1 ratio (p=0.008) compared to the older children. The girls showed higher values of MMP-1 (p=0.008) and MMP-1/TIMP-1 ratio (p=0.012) than the boys. The strong positive correlation between MMP-1 and InI in the children (ρ=0.514; p=0.001; 95% CI [0.232; 0.716]) was demonstrated. Using ordinal logistic regression method, a significant and simultaneously multidirectional dependence of InI categorical index on MMP-1 (B=1.078; p=0.013; 95% CI [0.223; 1.933]) and the age category of the examined children (B=-1.942; 95% CI [-3.757; -0.126]) was established.
Conclusions. It is assumed that more frequent ARIs in children are accompanied by higher levels of serum MMP-1. It is not unlikely that there is differential «tuning» of MMP-1 activity in response to varying frequency of ARIs during the previous year. The degree of influence of the predictor, namely MMP-1, in ordinal regression models is determined by both the significance of this predictor and the variant of its combination with other studied covariates.
The study was conducted in accordance with the principles of the Declaration of Helsinki. The study protocol was approved by the local ethics committees of the institutions mentioned in the paper. An informed parental consent was obtained for the study in children.
No conflict of interests was declared by the authors.
Keywords: preschool children, recurrent respiratory infections, matrix metalloproteinase 1, tissue inhibitor of matrix metalloproteinase 1.
REFERENCES
1. Agren MS, auf dem Keller U. (2020). Matrix Metalloproteinases: How Much Can They Do? International Journal of Molecular Sciences. 21 (8): 2678. https://doi.org/10.3390/ijms21082678; PMid:32290531 PMCid:PMC7215854

2. Apte SS, Parks WC. (2015). Metalloproteinases: A parade of functions in matrix biology and an outlook for the future. Matrix Biology. 44-46: 1-6. https://doi.org/10.1016/j.matbio.2015.04.005; PMid:25916966

3. Babichev SA. (2014). Optimization of information preprocessing in clustering systems of high dimension data. Radioelektronika, informatyka, upravlinnia. 2: 135-142. URL: https://cyberleninka.ru/article/n/optimizatsiya-protsessa-predobrabotki-informatsii-v-sistemah-klasterizatsii-vysokorazmernyh-dannyh/viewer. https://doi.org/10.15588/1607-3274-2014-2-19

4. Da Silva-Neto PV, do Valle VB, Fuzo CA, Fernandes TM, Toro DM, Fraga-Silva TFC et al. (2022). Matrix Metalloproteinases on Severe COVID-19 Lung Disease Pathogenesis: Cooperative Actions of MMP-8/MMP-2 Axis on Immune Response through HLA-G Shedding and Oxidative Stress. Biomolecules. 12 (5): 604. https://doi.org/10.3390/biom12050604; PMid:35625532 PMCid:PMC9138255

5. Fingleton B. (2017). Matrix metalloproteinases as regulators of inflammatory processes. Biochimica et Biophysica Acta – Molecular Cell Research. 1864 (11): 2036-2042. https://doi.org/10.1016/j.bbamcr.2017.05.010; PMid:28502592

6. Gautam SS, O'Toole RF. (2016). Convergence in the Epidemiology and Pathogenesis of COPD and Pneumonia. COPD: Journal of Chronic Obstructive Pulmonary Disease. 13 (6): 790-798. https://doi.org/10.1080/15412555.2016.1191456; PMid:27310416

7. Gelzo M, Cacciapuoti S, Pinchera B, De Rosa А, Cernera G, Scialò F et al. (2022). Matrix metalloproteinases (MMP) 3 and 9 as biomarkers of severity in COVID-19 patients. Scientific Reports. 12: 1212. https://doi.org/10.1038/s41598-021-04677-8; PMid:35075175 PMCid:PMC8786927

8. Gkouveris I, Nikitakis NG, Aseervatham J, Rao N, Ogbureke KUE. (2017). Matrix metalloproteinases in head and neck cancer: current perspectives. Metalloproteinases In Medicine. 4: 47-61. https://doi.org/10.2147/MNM.S105770

9. Hardy E, Fernandez-Patron C. (2021). Targeting MMP-Regulation of Inflammation to Increase Metabolic Tolerance to COVID-19 Pathologies: A Hypothesis. Biomolecules. 11 (3): 390. https://doi.org/10.3390/biom11030390; PMid:33800947 PMCid:PMC7998259

10. Huang X, Mu X, Deng L, Fu A, Pu E, Tang T, Kong X. (2019). The etiologic origins for chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Disease. 14: 1139-1158. https://doi.org/10.2147/COPD.S203215; PMid:31213794 PMCid:PMC6549659

11. Jabłońska-Trypuć A, Matejczyk M, Rosochacki S. (2016). Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs. Journal of Enzyme Inhibition and Medicinal Chemistry. 31 (1): 177-183. https://doi.org/10.3109/14756366.2016.1161620; PMid:27028474

12. Kachkovska VV. (2021). Matrix metalloproteinases as markers of respiratory tract remodeling and potential therapeutic target in patients with bronchial asthma. Eastern Ukrainian Medical Journal. 9 (2): 174-188. https://doi.org/10.21272/eumj

13. Karamanos NK, Theocharis AD, Piperigkou Z, Manou D, Passi A, Skandalis SS et al. (2021). A guide to the composition and functions of the extracellular matrix. Federation of European Biochemical Societies Journal. 288 (24): 6850-6912. https://doi.org/10.1111/febs.15776; PMid:33605520

14. Ke J, Ye J, Li M, Zhu Z. (2021). The Role of Matrix Metalloproteinases in Endometriosis: A Potential Target. Biomolecules. 11 (11): 1739. https://doi.org/10.3390/biom11111739; PMid:34827737 PMCid:PMC8615881

15. Krasnoselsky NV, Sukhin VS, Gertman VZ, Simonova-Pushkar LI. (2018). Applying matrix metalloproteinase in diagnosis and prognosis in oncogynecology. Actual problems of modern medicine. 18 (1): 313-317. URL: https://cyberleninka.ru/article/n/mozhlivosti-diagnostichnogo-ta-prognostichnogo-vikoristannya-matriksnih-metaloproteyinaz-v-onkoginekologiyi.

16. Laronha H, Caldeira J. (2020). Structure and Function of Human Matrix Metalloproteinases. Cells. 9 (5): 1076. https://doi.org/10.3390/cells9051076; PMid:32357580 PMCid:PMC7290392

17. Li Y, Fu X, Ma J, Zhang J, Hu Y, Dong W et al. (2019). Altered respiratory virome and serum cytokine profile associated with recurrent respiratory tract infections in children. Nature Communications. 10: 2288. https://doi.org/10.1038/s41467-019-10294-x; PMid:31123265 PMCid:PMC6533328

18. Potey PM, Rossi AG, Lucas CD, Dorward DA. (2019). Neutrophils in the initiation and resolution of acute pulmonary inflammation: understanding biological function and therapeutic potential. The Journal of Pathology. 247: 672-685. https://doi.org/10.1002/path.5221; PMid:30570146 PMCid:PMC6492013

19. Raeeszadeh-Sarmazdeh M, Do LD, Hritz BG. (2020). Metalloproteinases and Their Inhibitors: Potential for the Development of New Therapeutics. Cells. 9 (5): 1313. https://doi.org/10.3390/cells9051313; PMid:32466129 PMCid:PMC7290391

20. Ramírez-Martínez G, Jiménez-Álvarez LA, Cruz-Lagunas A, Ignacio-Cortés S, Gómez-García IA, Rodríguez-Reyna TS et al. (2022). Possible Role of Matrix Metalloproteinases and TGF-β in COVID-19 Severity and Sequelae. Journal of Interferon & Cytokine Research. 42 (8): 352-368. https://doi.org/10.1089/jir.2021.0222; PMid:35647937 PMCid:PMC9422783

21. Sarkar S, Ratho RK, Singh M, Singh MP, Singh A, Sharma M. (2022). Comparative Analysis of Epidemiology, Clinical Features, and Cytokine Response of Respiratory Syncytial and Human Metapneumovirus Infected Children with Acute Lower Respiratory Infections. Japanese Journal of Infectious Diseases. 75 (1): 56-62. https://doi.org/10.7883/yoken.JJID.2021.151; PMid:34193665

22. Sebina I, Phipps S. (2020). The Contribution of Neutrophils to the Pathogenesis of RSV Bronchiolitis. Viruses. 12 (8): 808. https://doi.org/10.3390/v12080808; PMid:32726921 PMCid:PMC7472258

23. Voloshin OM, Marushko YuV. (2021). Peculiarities of cellular immunity among preschool children suffering from recurrent respiratory diseases. Bulletin of problems biology and medicine. 1: 337-342. https://doi.org/10.29254/2077-4214-2021-1-159-337-342

24. XuChen X, Weinstock J, Arroyo M, Salka K, Chorvinsky E, Abutaleb K et al. (2021). Airway Remodeling Factors During Early-Life Rhinovirus Infection and the Effect of Premature Birth. Frontiers in Pediatrics. 9: 610478. https://doi.org/10.3389/fped.2021.610478; PMid:33718297 PMCid:PMC7952989

25. Young D, Das N, Anowai A, Dufour A. (2019). Matrix Metalloproteases as Influencers of the Cells' Social Media. International Journal of Molecular Sciences. 20 (16): 3847. https://doi.org/10.3390/ijms20163847; PMid:31394726 PMCid:PMC6720954

26. Zinter MS, Delucchi KL, Kong MY, Orwoll BE, Spicer AS, Lim MJ et al. (2019). Early Plasma Matrix Metalloproteinase Profiles. A Novel Pathway in Pediatric Acute Respiratory Distress Syndrome. American Journal of Respiratory and Critical Care Medicine. 199 (2): 181-189. https://doi.org/10.1164/rccm.201804-0678OC; PMid:30114376 PMCid:PMC6353006